-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CSfElLDCpjhSKCi7eur176twfdYKZGmx72J8w8iaF5RHHqIHy88K2/2OENATaUG2 GhmD2UKD7AJhHBQFst0vDg== 0000064670-04-000068.txt : 20041007 0000064670-04-000068.hdr.sgml : 20041007 20041007152605 ACCESSION NUMBER: 0000064670-04-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041007 FILED AS OF DATE: 20041007 DATE AS OF CHANGE: 20041007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ellis Gary Lee CENTRAL INDEX KEY: 0001290170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 041070221 BUSINESS ADDRESS: BUSINESS PHONE: 763-514-4000 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PARKWAY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2004-10-07 0000064670 MEDTRONIC INC MDT 0001290170 Ellis Gary Lee MEDTRONIC, INC. 710 MEDTRONIC PARKWAY, M.S. LC310 MINNEAPOLIS MN 55432-5604 0 1 0 0 VP, Corp Controller & Treas Common Stock 2004-10-07 4 M 0 896 6.625 A 9825.364 D Common Stock 2004-10-07 4 F 0 246 51.62 D 9579.364 D Common Stock 2004-10-07 4 S 0 650 51.62 D 8929.364 D Deferred Stock Units 1006.974 D Common Stock 3573.008 I By 401(k) Plan Common Stock 6110.973 I By ESOP Stock Options (Right to buy) 6.625 2004-10-07 4 M 0 896 6.625 D 2004-11-30 Common Stock 896 0 D Option grant under Medtronic's 1994 Stock Award Plan in transaction exempt under old Rule 16b-3. These options become exercisable at the rate of 10% of the shares granted per year beginning with the first anniversary of the grant. Carol E. Malkinson, Attorney-in-Fact 2004-10-07 -----END PRIVACY-ENHANCED MESSAGE-----